Previous studies have shown that
green tea catechins (GTCs) have beneficial effects on
obesity and
metabolic syndromes. In this study, we prepared kosen-cha from
green tea using high pressure extraction, to reduce the
astringent taste of the
green tea. We identified a large quantity of polymerized GTCs in kosen-cha. To investigate the effects of kosen-cha containing polymerized GTCs in obese Japanese patients, we designed an open-label pilot study in which 6 obese subjects (body mass index (BMI) >25 kg/m2) were administered kosen-cha (5 g/L/d) for 12 weeks. Body composition, serum
lipids,
insulin resistance, vascular functions, and
cardiac hypertrophy were measured before and 12 weeks after kosen-cha administration. Kosen-cha showed no significant adverse effects on the patients.
Body weights, BMI, waist circumferences, serum
triglyceride (TG) levels, and homeostasis model assessment as an index of
insulin resistance (HOMA-IR) levels were significantly decreased after the 12 weeks of administration. Flow-mediated dilation (FMD) (p = 0.0214), brachial-ankle pulse wave velocity (baPWV)(p = 0.0141), left ventricular mass indexes (p = 0.0120), and plasma
brain natriuretic peptide (BNP) (p = 0.0144) were significantly improved. Overall, kosen-cha reduced
obesity and improved
insulin resistance, vascular function, and
cardiac hypertrophy, indicating its preventive potential in
obesity and
metabolic syndrome.